Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression.

Apps JR, Gonzalez-Meljem JM, Guiho R, Pickles JC, Prince E, Schwalbe E, Joshi N, Stone TJ, Ogunbiyi O, Chalker J, Bassey A, Otto G, Davies R, Hughes D, Brandner S, Tan E, Lee V, Hayhurst C, Kline C, Castellano S, Hankinson T, Deutschbein T, Jacques TS, Martinez-Barbera JP

Open source

DOI: 10.1186/s40478-024-01838-4
Published: 2024 Aug 10
Container: Acta neuropathologica communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40478-024-01838-4,
  title = {Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression.},
  author = {Apps JR and Gonzalez-Meljem JM and Guiho R and Pickles JC and Prince E and Schwalbe E and Joshi N and Stone TJ and Ogunbiyi O and Chalker J and Bassey A and Otto G and Davies R and Hughes D and Brandner S and Tan E and Lee V and Hayhurst C and Kline C and Castellano S and Hankinson T and Deutschbein T and Jacques TS and Martinez-Barbera JP},
  year = {2024},
  journal = {Acta neuropathologica communications},
  doi = {10.1186/s40478-024-01838-4},
  url = {https://doi.org/10.1186/s40478-024-01838-4}
}

RIS

TY  - JOUR
TI  - Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression.
AU  - Apps JR
AU  - Gonzalez-Meljem JM
AU  - Guiho R
AU  - Pickles JC
AU  - Prince E
AU  - Schwalbe E
AU  - Joshi N
AU  - Stone TJ
AU  - Ogunbiyi O
AU  - Chalker J
AU  - Bassey A
AU  - Otto G
AU  - Davies R
AU  - Hughes D
AU  - Brandner S
AU  - Tan E
AU  - Lee V
AU  - Hayhurst C
AU  - Kline C
AU  - Castellano S
AU  - Hankinson T
AU  - Deutschbein T
AU  - Jacques TS
AU  - Martinez-Barbera JP
PY  - 2024
JO  - Acta neuropathologica communications
DO  - 10.1186/s40478-024-01838-4
UR  - https://doi.org/10.1186/s40478-024-01838-4
ER  -

APA

JR, A., JM, G., R, G., JC, P., E, P., E, S., N, J., TJ, S., O, O., J, C., A, B., G, O., R, D., D, H., S, B., E, T., V, L., C, H., C, K., S, C., T, H., T, D., TS, J., & JP, M. (2024). Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression.. Acta neuropathologica communications. https://doi.org/10.1186/s40478-024-01838-4

Source records

pubmed · retrieved 2026-09-26T23:33:59.309Z